DRUG · Unmapped registry intervention
DA-302168S
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of DA-302168S in Participants With Overweight/Obesity
NCT07629544
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
DA-302168S
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of DA-302168S in Participants With Overweight/Obesity
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Overweight and Obesityunresolved
Interventions
Sponsors & collaborators
Chendu DIAO Pharmaceutical Group CO., LTD.lead sponsor
Peking University People's Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07629544 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.